Jefferies, Piper Sandler, Cantor Fitzgerald and Barclays acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTMX:
- Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
- CytomX Therapeutics price target raised to $11 from $6 at Wedbush
- CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
- CytomX Therapeutics announces $250M common stock offering
- CytomX Therapeutics files automatic mixed securities shelf